The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $11,317,311 in first-year total cost, median $4,497,948.
Most frequent study sections
- Special Emphasis Panel[ZAI1 VS-A (S1)]2
- Special Emphasis Panel[ZAI1 PP-A (S1)]1
Most frequent institutions
- DUKE UNIVERSITY1
- FRED HUTCHINSON CANCER CENTER1
- WISTAR INSTITUTE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | Synthetic DNA-launched and adjuvanted Env immunogens for HIV1U19AI166916-01A1 | WEINER, DAVID B. | WISTAR INSTITUTE, PA | $4,497,948 | ZAI1 |
| 2023 | Self-amplifying mRNA-based vaccines to elicit VRC01-class bnAbs1U19AI174242-01 | STAMATATOS, LEONIDAS | FRED HUTCHINSON CANCER CENTER, WA | $2,099,783 | ZAI1 |
| 2022 | Conjugate nanoparticle platform development for HIV-1 envelope immunogens1U19AI160546-01A1 | SAUNDERS, KEVIN O | DUKE UNIVERSITY, NC | $4,719,580 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.